Showing 371-380 of 2072 results for "".
Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.AAD Treatment Evolution: The Future of Emerging Therapies
https://practicalneurology.com/programs/cme/aad-treatment-evolution-the-future-of-emerging-therapies/27103/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know
https://practicalneurology.com/programs/cme/early-warning-clinical-signs-of-aad-every-pcp-and-caregiver-should-know/27095/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Proactive Screening: Essential Tools for Diagnosing AAD Quickly
https://practicalneurology.com/programs/cme/proactive-screening-essential-tools-for-diagnosing-aad-quickly/27096/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Caregiver Screening Tools for Agitation in Alzheimer’s Disease
https://practicalneurology.com/programs/cme/caregiver-screening-tools-for-agitation-in-alzheimers-disease/28795/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
https://practicalneurology.com/programs/cme/safety-efficacy-and-black-box-warnings-challenges-associated-with-off-label-treatments-of-aad/27099/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Team Approach: Enhancing Collaboration in AAD Management
https://practicalneurology.com/programs/cme/team-approach-enhancing-collaboration-in-aad-management/27097/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Neurologic Assessment & Neuromonitoring in the COVID-19 Pandemic
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-assessment-neuromonitoring-in-the-covid-19-pandemic/31742/Noninvasive monitoring can help triage, monitoring at-risk persons, and assess the need for invasive monitoring modalities.